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Summary 
Injection of adult mice with high doses of monomeric human gamma globulins (dHGG) has 
been previously shown to produce a state of peripheral tolerance in both B and T cells. To gain 
insight into the mechanism of induction and maintenance of adult tolerance in this model, we 
have analyzed the pattern of lymphokines produced by control and tolerant animals in response 
to the tolerogen. The data presented indicate that HGC~specific, interleukin 2 (IL-2)- and interferon 
3' (IFN'q')'producing T cells (thus referred to as T helper type 1 [Thl] cells) are rendered unresponsive 
after in vivo administration of soluble HGG. In contrast, antigenic stimulation of T cells isolated 
from tolerant adult mice leads to increased production of IL-4 in vitro. In vivo challenge ofdHGG- 
treated  adult animals with hapten-coupled  HGG (p-azophenylarsonate  [ARS]-HGG) induced 
a significant ARS-specific antibody response, suggesting that tolerance induction in this model 
does not completely abrogate tolerogen-specific Th activity in vivo. In agreement with the in 
vitro data, hapten-specific antibody response of tolerant  animals is characterized by a selective 
deficiency in the IFN-q,-dependent  IgG2a subclass. Injection of immunogenic forms of HGG 
into tolerant animals also produced an IL-4-dependent increase in total serum IgE levels, indicative 
of an increased activity of HGG-specific Th2 cells in these animals. The finding that tolerance 
induction differentially affects Th subpopulations suggests that crossregulation among lymphocyte 
subsets may play a role in the induction and/or maintenance of acquired tolerance in adults. 
A  prime aim in the treatment of allograft rejection and 
autoimmune disorders is to convert antigen recognition 
by a mature immune system into a state of specific immune 
unresponsiveness. Although induction of immune tolerance 
in adults meets difficulties, antigen-specific unresponsiveness 
in mature lymphocytes has been induced in vivo by intrave- 
nous administration of allogeneic (1) or Mls-disparate cells 
(2),  hapten-coupled syngeneic cells (3, 4),  soluble antigen 
(5), and antigen-pulsed, chemically modified, syngeneic cells 
(6). In most cases described, induction of unresponsiveness 
does not require a thymic environment (7, 8), and appears 
to be mediated by clonal anergy rather than clonal deletion 
(2, 9). 
Th unresponsiveness  can be induced in vitro by confronting 
mature lymphocytes with antigen-pulsed, purified MHC mol- 
ecules (10), chemically (6) or UV-treated APC (11), high doses 
of antigen (12), or Ib2 (13). 
It is noteworthy that, in most systems described to date, 
different sensitivities to tolerance induction in vitro have been 
noticed when murine helper clones producing distinct pat- 
terns of lymphokines were studied. In particular, only IL-2- 
producing CD4 + clones (14, 15), and more recently CD8 § , 
Ib2-producing clones (16), have been shown to be suscep- 
tible to anergy induction by chemically damaged APC. Ib4- 
producing clones (Th2 cells) appear to be resistant to in vitro 
tolerance induction under the same experimental conditions. 
These findings, together with the recent evidence showing 
that selective activation of Th subsets can lead to strikingly 
different immune effector functions (17), prompted us to study 
whether CD4 + Th subsets from adult animals were equally 
sensitive to tolerogenic signals delivered by in vivo adminis- 
tration of soluble human gamma globulins (HGG). 1 
Data  are  presented  showing  that  under  identical  ex- 
perimental conditions,  soluble antigen-induced Thl clonal 
anergy/deletion, and Th2 donal activation/expansion.  These 
1 Abbreviations used in tkis paper: ARS, p-azophenylarsonate;  HGG, human 
gamma globulin. 
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play a role in the maintenance of acquired tolerance in adults. 
Materials and Methods 
Animals, Reagents, andlmmunizations.  A/J mice were purchased 
from The Jackson Laboratory (Bar Harbor, ME) and were used 
between 8 and 12 wk of age. To induce tolerance to HGG (CH- 
9470; Fluka Chemie AG, Buchs, Switzerland),  Img of monomeric, 
deaggregated HGG (dHGG; obtained by centrifugation at 150,000 
g  for  180  rain)  was  injected into  the  peritoneal cavity (in- 
traperitoneally) of adult mice on day 0. Animals were challenged 
intraperitoneally on day 15 with 100 #g of ARS-HGG (18) or 300 
/~g of HGG emulsified  in CFA (Difco Laboratories, Detroit,  MI) 
subcutaneously at the tail base and in the footpads. Secondary re- 
sponses to HGG- p-azophenylarsonate (ARS) were elicited by in- 
jecting intraperitoneally 100/~g of antigen in saline. In vivo treat- 
ment with anti-IL-4 antibodies was performed as follows (see 
reference 19). Mice received three intraperitoneal  injections of 1 ml 
of ascitic fluid containing 5 mg of rat IgG1 mAbs specific  for rou- 
tine II--4 (clone llBll) or the hapten DNP (control group, clone 
LO-DNP-1). Ascites were injected I d before and on the day of 
antigenic challenge, as well as 4 d later. 
Assay.for Serum Antibodies.  Serum  levels of antigen-specific  an- 
tibodies were determined by ILIA and ELISA according to stan- 
dard procedure using anti-mouse Ig antibodies  known to react with 
all murine isotypes. When indicated, enzyme-labeled rat mAbs 
specific for murine IgG1 (clone  LO-MG1-D) and IgG2a (LO-MG2a- 
7) (20) were used as secondary reagents. 
Total serum IgE levels were determined by ELISA using two 
rat mAbs specific  for nonoverlapping epitopes on mouse IgE (20). 
Briefly, at~nity-purified  mAb LO-ME-D was used as capture anti- 
body and absorbed to microtiter plates. After addition of serial di- 
lutions  of serum sample, plates were revealed with peroxidase- 
coupled LO-ME-2 mAb. Standard curves were generated using a 
calibrated source of monodonal murine IgE (done LB4; 20). 
T CelIProliferation.  All in vitro assays  were performed in com- 
plete media as described (19). Responder cells were isolated from 
the draining lymph nodes of control and experimental animals and 
depleted of most B and accessory cells by negative selection on 
RaMIg-coated plates. 105 responder cells and 10  s APC  (Thy-1- 
depleted naive spleen  cells) were incubated in 96-well  culture plates 
(Falcon 3072; Becton Dickinson & Co., OxnaM, CA) in the pres- 
ence or absence of serial dilution of antigen (HGG). Proliferation 
was assessed in these cultures by measuring [3H]thymidine  incor- 
poration during the last 18 h of a 72-h incubation period. 
Lymphokine Assays.  Antigen-driven IIr  production was mea- 
sured by a standard bioassay using a subdone of the CTL.L cell 
line insensitive to murine IL-4 (21). Proliferation of this cell line 
induced by supernatants from antigen- or anti-CD3-stimulated T 
cell cultures is completely  inhibitable  by the anti-murine Ib2 mAb 
$4B6. Standard curves were generated using human rll.-2 and su- 
pernatants from antigen-stimulated cultures were assayed after 
40-48 h of incubation. 
Ib4 production was monitored by a bioassay  based on the ability 
of Ib4 to increase Ia expression on B cells, as previously described 
(19). Briefly, responder T cells were incubated with antigen and 
B cells (Thy-l-depleted naive spleen cells). After 36-40 h of cul- 
ture, cells  were harvested  and stained  with fluorescein-labeled  14.4.4 
mAb (anti-I-Ek'd). The mean channel fluorescence  of class II-posi- 
tive cells  was determined by FACScan  |  (Becton Dickinson & Co.). 
A  linear standard curve was  generated by incubating  Thy-1- 
spleen cells with serial dilutions of murine rib4 (range, 0.02-4 
U/ml; mean channel FL1 range, 177-1752). Increased  fluorescence 
in antigen-stimulated culture was shown to be mediated by II.,4 
since inhibition  by anti-IL-4  mAbs always  exceeded  90%. The results 
are expressed as the mean of three independent determinations. 
IFN-3, production by antigen-stimulated lymph node cells was 
evaluated  by a commercially  available  ELISA  test kit (Holland Bio- 
technology,  Leiden,  Holland) using two mAbs specific  for nonover- 
lapping epitopes on mouse IFN-% Briefly, lymph node cells iso- 
lated from control and tolerant immune animals were cultured at 
5  x  106/mi in 1-ml cultures (Falcon 3047; Becton Dickinson & 
Co.) with or without antigen (HGG; 2 mg/ml). Superuatants  were 
collected after 40 h of culture and assayed for IFN-3~ content ac- 
coming to the manufacturer's recommendations. 
Results and Discussion 
Experimental Design.  Injection of dHGG has been widely 
used to induce unresponsiveness  in adult animals.  In this 
model, it has been shown that mice treated with dHGG failed 
to produce HGG-specific antibodies after challenge with im- 
munogenic forms of HGG emulsified in CFA (5). More rele- 
vant to this study, peripheral T  cells isolated from tolerant 
animals showed a diminished proliferative response to HGG 
in vitro (8). This state of peripheral tolerance could be in- 
duced in the absence of thymic environment and was inde- 
pendent of CD8 + suppressor  activity (8,  22). 
In this study, HGG tolerance was induced in adult A/J 
mice by injecting 1 mg of dHGG as described  in Materials 
and Methods. Fig. 1 indicates that immune responses elicited 
by immunogenic doses of HGG were impaired in tderant 
animals. In particular, no significant antibody production was 
detected in the serum of tolerant mice after injection of HGG 
in CFA as compared with control animals (Fig.  1 a). 
Antigen-specific T  cell proliferation by tolerant (dHGG- 
treated) or control (untreated) mice was evaluated  after in 
vivo challenge with immunogenic doses of HGG (in CFA) 
and in vitro restimulation with soluble HGG and APC. As 
shown in Fig. 1 b, HGG-specific T ceU proliferation was re- 
duced in tolerant animals, although a weak, but significant 
response was deafly demonstrable. No proliferation was ob- 
served when animals were treated with CFA alone (Fig.  1 
b, open symbols). In all cases examined, reduction of prolifera- 
tive capacities was only observed in response to HGG, since 
anti-CD3-induced proliferation was not affected by tolerance 
induction (data not shown). 
In Vitro Lyraphokine Production.  To assess the immuno- 
competence of tolerant animals, the following experiments 
were performed. As for proliferation, control and tolerant 
animals were challenged in vivo with immunogenic doses 
of HGG in CFA. Responder cells isolated from draining lymph 
nodes 10-15  d later were stimulated in vitro with antigen 
and naive APCs and assayed  for lymphokine production. Data 
obtained from two independent experiments are presented 
in Fig. 2. The top two panels represent the pattern of Ib2 
and Ib4 production after in vitro restimulation of control 
and tolerant animals. Under identical experimental conditions, 
tolerant animals failed to produce significant levels of Ib2 
in the presence of the tolerogen, while secreting high levels 
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Figure 1.  Immune  unresponsiveness  induced by dHGG. 
dHGG-treated (triangles) or untreated (circles) mice (n = 
3) were injected with HGG/CFA (filled symbols) or adju- 
vant alone (open symbols).  Animals were bled and killed 
14 d later, and the immune response towards HGG was 
assayed as described. Antibody response (a) is assayed by 
solid-phase ILIA. Proliferative response (b) is determined 
by [3H]Thy incorporation from antigen-stimulated lymph 
node cultures (triplicate cultures). Results are expressed 
as the mean (_+  SD) of three individual determinations. 
of Ib4 in response to the same stimulus (Fig. 2, top and m/dd/e). 
In contrast,  control animals produce high levels of II.,2 and 
low amounts of IL-4 in response to antigen. No lymphokines 
were secreted by animals treated in vivo with CFA only (data 
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Split tolerance in dHGG-treated mice. Lymph node cells from 
control (n = 3, hatched bars) and tolerant (n = 3, crosshatched bars) animals 
were cultured in the presence (+) or absence (-) of HGG (2 mg/ml) and 
assayed for lymphokine production as indicated.  (Tbp and middle)  Data 
from a single experiment in which each individual mouse was tested for 
both IL-2 and Ib4 production. (Bottom)  A separate experiment performed 
according to the same general protocol except that IFN-3, production was 
assayed by ELISA. 
not shown). All animals produced  identical  levels of lym- 
phokines (II.-2 and II.-4) upon stimulation by anti-CD3 anti- 
bodies in vitro  (data not shown). 
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Figure 3.  Altered in vivo isotype expression in tolerant mice. Control 
(open symbols)  and tolerant (filled symbols) animals (n = 5) were immunized 
with ARS-HGG and the HGG, and ARS-specific antibody response was 
determined by ELISA. HGG- (top left) and ARS-BSA-coated plates were 
incubated with serial dilutions of immune (circles) or normal (open triangles) 
serum and revealed by enzyme-labeled goat antibodies reactive with all 
murine isotypes (top), or subclass-speciiic  rat anti-mouse Ig mAb (bottom). 
Results are expressed as the mean (+  SD) of five individual determina- 
tions in each experimental group. 
11  De Wit  et  ~d. In a separate experiment, cells isolated from antigen-boosted, 
control and tolerant animals were assayed for their produc- 
tion of IFN-y in response to antigen restimulation in vitro. 
The results obtained (Fig. 2, bottom) are indicative of a pro- 
found suppression of tolerogen-specific,  IFN-3' production 
in tolerant animals. As in the previous group, these animals 
displayed an increased production of I1.4 in response to HGG 
(data not shown). 
Thus, in viva exposure to tolerogenic forms of HGG results 
in priming of antigen-specific,  I1.4-producing T  cells, and 
functional inactivation of antigen-specific,  I1.2- and IFN-3' 
secreting cells. 
In Viva Isotype Expression,  We next wished to investigate 
whether the distinct in vitro response of Thl and Th2 cells 
after tolerance induction was also observed in viva. For this 
purpose, we designed an experiment that relies on the dis- 
tinct function of Th subsets in the regulation of Ig isotype 
production. In particular,  it has been demonstrated that Thl 
clones induced antigen-specific B cells to secrete IgG2a Igs, 
while Th2 clones favor the production of IgG1 and IgE (23). 
Since dHGG treatment induces B cell tolerance (5), the helper 
activity of HGG-specific T cells was studied in viva after chal- 
lenge with hapten-coupled HGG (ARS-HGG). In this situ- 
ation, most of the hapten-specific  antibody response is de- 
pendent upon help provided by carrier-reactive  T  cells. 
The humeral secondary response to both HGG and ARS 
is shown in Fig. 3. As previously shown by others, tolerant 
animals displayed a profound impairment of the HGG-specific 
antibody response (Fig. 3, top left). Inhibition of the tolerogen- 
specific antibody production exceeded  99% in this experiment. 
In contrast, tolerant animals retained a significant  antibody 
production to the ARS hapten (Fig. 3, top right). Although 
the presence of ARS-specific, Th cells cannot be formally ex- 
cluded, this finding is consistent with the in vitro data and 
suggests that HGG-specific  helper functions are not totally 
abrogated in dHGG-treated animals. Analysis of the subclass 
profile revealed a selective  deficiency  of the ARS-specific, IgG2a 
subclass antibody production in tolerant animals (>100-fold 
reduction), compatible with the selective deficiency in IFN-y 
production observed in vitro. As shown in Fig. 3, produc- 
tion of ARS-specific, IgG1 was not affected to the same ex- 
tent in tolerant animals (approximately fourfold reduction). 
The possible effects of in vivo I1:4 production in dHGG- 
treated animals was then evaluated. As shown in Fig. 4, in- 
jection of ARS-HGG (or HGG alone; data not shown) caused 
a marked increase in total serum IgE levels in tolerant but 
not control animals. ELISAs failed to show any IgE reactivity 
to either ARS or HGG, suggesting that most IgE secreted 
were from polyclonal orion. Hyper-IgE production was com- 
pletely abrogated by in vivo treatment with anti-I1.4 mAbs 
but not with DNP-specific, control antibodies, indicating that 
increased production of I1.4 in response to ARS-HGG was 
responsible  for the elevated serum levels of IgE. 
Of note, injection of ARS-KLH in dHGG-treated animals 
induced normal levels of ARS-specific antibodies of the IgG2a 
subclass and only minimal increase in total serum IgE level, 
indicating that tolerance induction in this system only affects 
HGG-specific T and B lymphocytes (data not shown). Thus, 
the antibody profile observed after immunization of tolerant 
animals  with  ARS-HGG  is  compatible with  a  selective 
deficiency in Thl cells required for IgG2a production and 
increased activity of Th2 cells leading to IgE production. 
Conclusions.  The major observation from this study is that 
Th subsets are not equally sensitive to tolerance induction 
in viva.  Injection of adult animals with dHGG induced a 
state of immune tolerance characterized by a selective  deficiency 
in II-2 and IFN-~/antigen-specific production. 
The finding that Thl and Th2 clones differ in their re- 
quirement for costimulatory signals delivered by APC offers 
an explanation to the results reported in this study. The cur- 
rent hypothesis is that stimulation of Thl clones, but not 
Th2 clones, requires both receptor triggering and a costimula- 
tory signal delivered by APCs. Inappropriate APCs (lacking 
the costimulatory factor) not only fail to induce proliferation 
of Thl clones, but also induce a state of unresponsiveness (14). 
Of interest, it has been demonstrated that antigen presented 
by B cells stimulates optimal proliferation of Th2 but not 
Thl clones (24).  It is therefore tempting to postulate that 
deaggregated, monomeric HGG is preferentially presented 
in viva by resting B cells, perhaps through Fc receptor-facili- 
tated endocytosis. Antigen presented by B cells (lacking the 
putative costimulatory factor) may cause Thl clonal anergy 
but Th2 clonal expansion/activation. As a consequence, im- 
munogenic challenge with HGG will selectively amplify the 
Th2 subset and the production of lymphokines required for 
IgG1 and IgE synthesis. 
Of interest, we and others (25-28) have recently reported 
that neonatally induced tolerance to alloantigens is similarly 
restricted to the Thl subset.  Donor-specific Th2 cells not 
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Figure 4.  Induction of in viva IgE production in tolerant mice and role 
of II-4. Control (open bars) and tolerant (hatched bars) mice (n  =  3) were 
either left untreated  (mean serum IgE, respectively, 170 and 370 ng/ml) 
or injected with ARS-HGG (mean serum IgE 7 d after in viva challenge, 
610 and 4,100 ng/ml, respectively). The mAb treatment consisted of a 
total dose of 15 mg of the 111tll anti-I1-4 mAb or the LO-DNP-1 control 
mAb administered as indicated in Materials and Methods. Data are presented 
as the mean (_+ SD) of three individual determinations in each experimental 
group. 
12  T  Helper Cell Subsets and Immune Tolerance only escape tolerance in this system but are responsible for 
the development of a systemic autoimmune disorder associated 
with increased production of IgG1 and IgE isotypes (HVGD) 
(see reference 28). Thus, in both experimental systems (toler- 
ance to alloantigens and to HGG), IL-4-producing Th2 cells 
appear to be resistant to peripheral tolerance as if immune 
stimuli that induce Thl tolerance activate Th2 cells or in- 
duce mulfipotent precursors to differentiate in a Th2-type cell. 
Crossregulation  between  Th  subsets  has  been  clearly 
documented although its physiological significance remains 
to be established. In particular,  activated Th2 cells could pro- 
duce IL-10, a cytokine that suppress the production of  cytokines 
by Thl cells responding to antigen and APC (29). Preferen- 
tial activation of the Th2 subset could result in the produc- 
tion of soluble factors inhibiting Thl functions and/or differen- 
tiation of thymic precursors into Thl cells. The present study 
may therefore provide a useful model to explore the in vivo 
requirements of Th subset activation in response to a foreign 
antigen and the potential role of Th2 cells or Th2-derived 
factors in the maintenance of the tolerant state in adult animals. 
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